A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer

A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer

Abstract only

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 23; no. 16_suppl; p. LBA4009
Main Authors: Riess, H., Helm, A., Niedergethmann, M., Schmidt-Wolf, I., Moik, M., Hammer, C., Zippel, K., Weigang-Köhler, K., Stauch, M., Oettle, H.
Format: Journal Article
Language:English
Published: 01-06-2005
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Abstract only
AbstractList Abstract only
Author Hammer, C.
Niedergethmann, M.
Schmidt-Wolf, I.
Stauch, M.
Helm, A.
Riess, H.
Moik, M.
Zippel, K.
Oettle, H.
Weigang-Köhler, K.
Author_xml – sequence: 1
  givenname: H.
  surname: Riess
  fullname: Riess, H.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
– sequence: 2
  givenname: A.
  surname: Helm
  fullname: Helm, A.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
– sequence: 3
  givenname: M.
  surname: Niedergethmann
  fullname: Niedergethmann, M.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
– sequence: 4
  givenname: I.
  surname: Schmidt-Wolf
  fullname: Schmidt-Wolf, I.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
– sequence: 5
  givenname: M.
  surname: Moik
  fullname: Moik, M.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
– sequence: 6
  givenname: C.
  surname: Hammer
  fullname: Hammer, C.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
– sequence: 7
  givenname: K.
  surname: Zippel
  fullname: Zippel, K.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
– sequence: 8
  givenname: K.
  surname: Weigang-Köhler
  fullname: Weigang-Köhler, K.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
– sequence: 9
  givenname: M.
  surname: Stauch
  fullname: Stauch, M.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
– sequence: 10
  givenname: H.
  surname: Oettle
  fullname: Oettle, H.
  organization: Deutsche Krebsgesellschaft; Charité Virchow Klin, Berlin, Germany; Klin Mannheim, Ruprecht-Karls-Universität, Mannheim/Heidelberg, Germany; Klin Bonn, Friedrich-Wilhelms-Universität, Bonn, Germany; Landeskliniken Salzburg, Salzburg, Austria; Humaine Klin Bad Saarow, Bad-Saarow, Germany; Oscar-Ziethen-Krankenhaus, Berlin, Germany; Klin Nürnberg Nord, Nürnberg, Germany; Outpatient Dept Stauch, Kronach, Germany
BookMark eNpNkM1qGzEUhUVJoU7ad7iLLlrwTPVjeUbQTQhNYwh000B34lq6ahRkzSCNXfpQfcfKNIWsDpxzfzjfJbvIUybG3gveC8n5pyc39U11L1UvtrYe5zn1aY8bzs0rthJaDt0waH3BVnxQshOj-vGGXdb6xLnYjEqv2J9rKJj9dIiV_BrmMtWZ3BJPtIbDMS3RUV6otOQRK8Fut4OlREwwBfhJBxcX3MfchnUX0nEq07Ggiwk-6O724eMawpRijg6a6eFU-5dLgKn1gZhhxiW2PxV-xeUR0J8wO_LNzq5Qyxy4s1PestcBU6V3z3rFHm6_fL-56-6_fd3dXN93TghpOuNcUMYF4qPhcot60BuzQbnf7hGFJD8GbaRSXkni6L3ZymEwI448IBH36op9_nfXNR61ULBziQcsv63g9ozeNvT2jN5KZf-jt8_o1V-x0oDG
CitedBy_id crossref_primary_10_3748_wjg_v12_i43_6973
crossref_primary_10_1038_sj_bjc_6605377
crossref_primary_10_1016_j_dld_2014_01_001
crossref_primary_10_2958_suizo_29_878
crossref_primary_10_1016_S1658_3876_08_50008_2
crossref_primary_10_1016_S1499_3872_15_60344_7
crossref_primary_10_1186_1471_2407_8_361
crossref_primary_10_1007_s12094_009_0357_3
crossref_primary_10_1016_j_critrevonc_2006_02_004
crossref_primary_10_1200_JCO_2005_05_1490
crossref_primary_10_1517_14656566_9_9_1595
crossref_primary_10_1007_s00280_009_0980_2
crossref_primary_10_1200_JCO_2006_09_2551
crossref_primary_10_1200_JCO_2006_09_9788
crossref_primary_10_1200_JCO_2006_09_0886
crossref_primary_10_2165_00024669_200605040_00002
crossref_primary_10_1093_jjco_hyl067
crossref_primary_10_1097_CAD_0b013e3280121334
crossref_primary_10_1007_s12094_011_0618_9
crossref_primary_10_1038_ncpgasthep1097
crossref_primary_10_1007_s00280_005_0167_4
crossref_primary_10_1016_j_bbcan_2015_04_003
crossref_primary_10_1002_14651858_CD011044_pub2
crossref_primary_10_1634_theoncologist_2007_0181
crossref_primary_10_1016_j_ejca_2012_08_019
crossref_primary_10_1038_nrclinonc_2009_236
crossref_primary_10_1586_14737140_7_4_533
crossref_primary_10_1634_theoncologist_11_6_612
crossref_primary_10_1200_JCO_2013_48_7660
crossref_primary_10_1517_14656566_2015_1024654
crossref_primary_10_1016_j_ctrv_2008_11_007
crossref_primary_10_1007_s12029_012_9466_2
crossref_primary_10_1053_j_seminoncol_2007_05_009
crossref_primary_10_1053_j_seminoncol_2007_01_006
crossref_primary_10_1111_j_1443_9573_2007_00314_x
crossref_primary_10_2174_1871530320666200516164911
crossref_primary_10_1053_j_seminoncol_2021_01_001
crossref_primary_10_1200_JCO_2006_09_4664
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1200/jco.2005.23.16_suppl.lba4009
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1527-7755
EndPage LBA4009
ExternalDocumentID 10_1200_jco_2005_23_16_suppl_lba4009
GroupedDBID ---
.55
.GJ
08G
08P
0R~
18M
29K
2WC
34G
39C
3O-
4.4
53G
5GY
5RE
5VS
8F7
8WZ
A6W
AAKAS
AAQOH
AAQQT
AARDX
AAWTL
AAYEP
AAYOK
AAYXX
ABJNI
ABOCM
ACGFO
ACGFS
ACGUR
ADBBV
ADZCM
AEGXH
AENEX
AFFNX
AI.
AIAGR
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AWKKM
AZFZN
BAWUL
C45
CITATION
CS3
D-I
DIK
EBS
EJD
EX3
F5P
F9R
FBNNL
FD8
FEDTE
GX1
H13
HVGLF
HZ~
IH2
IPNFZ
J5H
K-O
KQ8
L7B
LSO
MJL
N4W
N9A
NTWIH
O9-
OK1
OVD
OWW
P2P
QTD
R1G
RHI
RIG
RLZ
RUC
SJN
SV3
TEORI
TR2
TWZ
UDS
UHU
VH1
VVN
WH7
WOQ
WOW
X7M
YCJ
YFH
YQY
ZGI
ID FETCH-LOGICAL-c1129-9ccf39cfe089026a575494a2b6baa12ed8f59233d32e0add9627798a80faee0d3
ISSN 0732-183X
IngestDate Fri Aug 23 01:44:47 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 16_suppl
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1129-9ccf39cfe089026a575494a2b6baa12ed8f59233d32e0add9627798a80faee0d3
ParticipantIDs crossref_primary_10_1200_jco_2005_23_16_suppl_lba4009
PublicationCentury 2000
PublicationDate 2005-06-00
PublicationDateYYYYMMDD 2005-06-01
PublicationDate_xml – month: 06
  year: 2005
  text: 2005-06-00
PublicationDecade 2000
PublicationTitle Journal of clinical oncology
PublicationYear 2005
SSID ssj0014835
Score 1.8176935
Snippet Abstract only
SourceID crossref
SourceType Aggregation Database
StartPage LBA4009
Title A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa2IU28IBgg7joPYwIl6ZpbkzwW6NQiVk20E3uLHDteg9pmWluk_Sj-I8exnaRMQgOJl6i1lZOo5-u5-VwIOcxjlLysSx2Xh9xBULgORb3m-KjrAiqihDMZGhhOovFF_GkQDHZ2TYJss_ZfOY1ryGtZOfsX3K6J4gJ-Rp7jFbmO1zvxvW-h9uElsk-FMVFCmmpK-bVKIJQZmYpVVzPUYtZoNLLU-A40HS_zBSvWNCtUrDN0xHxTXuOjKSvm0iANnZPzt14iN0VZFVZauMWtH6tO-2aLzkvVkkT3bjWFdCbrAOWQMlmZTD1jOk34tqFcF2-WS7Z1CPAVvfwKhsNOE9JVMd5-vTIuZLuMy3w9W-h50Kf13oTNFgVfO9_KedWbctTZCoKETbKWlpWR7zkonS6UWtOy3IvQeVBdgI2wV8XNBtS9dCVnp7YE-JcPfZRqScseaK3cUjdeNUn7OytVcM7zO4ZkZ57RhlC7y_dv2rfOiZTeGFJJkZqcDRqmnp8aaqmmtkvueShQpTyffB7Xp2VBrAbJmh9hnxzqtzv-07u1TLGWTTV9SB5oHkNfofgR2cmXB2T_VKd7HJCjM9VY_caGaVMnuLLhCM6alus3j8nPPjSot6GFeRtaiMcdiXdAvEOFdygFtCBrwzba4Z3E-nsbNM5B4hwQ5-2boMI5FEswOAeJczA4hwbnoHD-hJyfDKYfh44eROIw6Y44CWPCT5jIu_JUvkfRxQmSgHpZL6PU9XIeixAdJZ_7Xt5Fg0EOtIqSmMZdQfO8y_2nZG-Jr_KMgHBpwHu9xBU-2o8ioR6NmI9eQeaGmZtEz0loeJJeqX4z6V2Q8eIf73tJ7jf_p1dkb329yV-T3RXfvKkw9gtfgtUE
link.rule.ids 315,782,786,27933,27934
linkProvider Multiple Vendors
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+randomised%2C+prospective%2C+multicenter%2C+phase+III+trial+of+gemcitabine%2C+5-fluorouracil+%285-FU%29%2C+folinic+acid+vs.+gemcitabine+alone+in+patients+with+advanced+pancreatic+cancer&rft.jtitle=Journal+of+clinical+oncology&rft.au=Riess%2C+H.&rft.au=Helm%2C+A.&rft.au=Niedergethmann%2C+M.&rft.au=Schmidt-Wolf%2C+I.&rft.date=2005-06-01&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=23&rft.issue=16_suppl&rft.spage=LBA4009&rft.epage=LBA4009&rft_id=info:doi/10.1200%2Fjco.2005.23.16_suppl.lba4009&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_jco_2005_23_16_suppl_lba4009
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon